{"id":687861,"date":"2022-09-22T05:49:21","date_gmt":"2022-09-22T09:49:21","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/"},"modified":"2022-09-22T05:49:21","modified_gmt":"2022-09-22T09:49:21","slug":"abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","title":{"rendered":"ABT LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\">NEW YORK\u00a0<\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Sept. 22, 2022<\/span><\/span> \/PRNewswire\/ &#8212; Levi &amp; Korsinsky, LLP notifies investors in <b>Abbott Laboratories<\/b> (&#8220;Abbott&#8221; or the &#8220;Company&#8221;) (NYSE: ABT) of a class action securities lawsuit.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.jpg\" title=\"Levi &amp; Korsinsky, LLP (PRNewsfoto\/Levi &amp; Korsinsky, LLP)\" alt=\"Levi &amp; Korsinsky, LLP (PRNewsfoto\/Levi &amp; Korsinsky, LLP)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>CLASS DEFINITION: <\/b>The lawsuit seeks to recover losses on behalf of Abbott investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities who purchased or otherwise acquired shares of Abbott common stock during the period from <span class=\"xn-chron\">February 19, 2021<\/span>, to <span class=\"xn-chron\">June 8, 2022<\/span>, inclusive. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n<p>\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3655865-3&amp;h=3835925058&amp;u=https%3A%2F%2Fwww.zlk.com%2Fpslra-1%2Fabbott-laboratories-class-action-lawsuit-submission-form%3Fprid%3D32018%26wire%3D4&amp;a=https%3A%2F%2Fwww.zlk.com%2Fpslra-1%2Fabbott-laboratories-class-action-lawsuit-submission-form%3Fprid%3D32018%26wire%3D4\" rel=\"nofollow\">https:\/\/www.zlk.com\/pslra-1\/abbott-laboratories-class-action-lawsuit-submission-form?prid=32018&amp;wire=4<\/a>\n      <\/p>\n<p>\n        <b>ABT<\/b>\u00a0investors may also contact <span class=\"xn-person\">Joseph E. Levi, Esq.<\/span> via email <a href=\"mailto:at\u00a0jlevi@levikorsinsky.com\u00a0or\" rel=\"nofollow\">at\u00a0jlevi@levikorsinsky.com\u00a0or<\/a> by telephone at (212) 363-7500.<\/p>\n<p>\n        <b>CASE DETAILS: <\/b>According to the filed complaint, defendants touted the strength of Abbott&#8217;s infant formula brands and their contribution to the Company&#8217;s sales and revenue growth, despite knowing that the facility that manufactured those products was in flagrant violations of United States Food and Drug Administration (&#8220;FDA&#8221;) health, safety, and manufacturing regulations. The complaint further alleges that defendants willfully or recklessly concealed these violations from investors, even though the violations put Abbott&#8217;s infant formula business in dire jeopardy and left the Company exposed to a risk of severe regulatory action, including the recall of its products and closure of the Sturgis facility. Indeed, according to the complaint, defendants received direct warnings, communications, FDA inspection reports, and consumer complaints identifying in detail the safety and regulatory violations that were rampant at the Sturgis facility.<\/p>\n<p>\n        <b>WHAT&#8217;S NEXT? <\/b>If you suffered a loss in Abbott during the relevant time frame, you have until <b><span class=\"xn-chron\">October 31, 2022<\/span><\/b>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p>\n        <b>NO COST TO YOU: <\/b>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. <b>There is no cost or obligation to participate.<\/b><\/p>\n<p>\n        <b>WHY LEVI &amp; KORSINSKY: <\/b>Over the past 20 years, the team at Levi &amp; Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services&#8217; Top 50 Report as one of the top securities litigation firms in <span class=\"xn-location\">the United States<\/span>.<\/p>\n<p>\n        <b>CONTACT:<\/b><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP <br \/><span class=\"xn-person\">Joseph E. Levi, Esq.<\/span><br \/><span class=\"xn-person\">Ed Korsinsky, Esq.<\/span><br \/>55 Broadway, 10th Floor<br \/><span class=\"xn-location\">New York, NY<\/span> 10006<br \/><a href=\"mailto:jlevi@levikorsinsky.com\" rel=\"nofollow\">jlevi@levikorsinsky.com<\/a><br \/>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3655865-3&amp;h=1159707&amp;u=http%3A%2F%2Fwww.zlk.com&amp;a=www.zlk.com\" rel=\"nofollow\">www.zlk.com<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY81009&amp;sd=2022-09-22\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow noopener\" href=\"https:\/\/www.prnewswire.com\/news-releases\/abt-lawsuit-alert-levi--korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-301630480.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/abt-lawsuit-alert-levi&#8211;korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-301630480.html<\/a><\/p>\n<p>SOURCE  Levi &amp; Korsinsky, LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY81009&amp;Transmission_Id=202209220545PR_NEWS_USPR_____NY81009&amp;DateId=20220922\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK\u00a0, Sept. 22, 2022 \/PRNewswire\/ &#8212; Levi &amp; Korsinsky, LLP notifies investors in Abbott Laboratories (&#8220;Abbott&#8221; or the &#8220;Company&#8221;) (NYSE: ABT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Abbott investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities who purchased or otherwise acquired shares of Abbott common stock during the period from February 19, 2021, to June 8, 2022, inclusive. Follow the link below to get more information and be contacted by a member of our team: https:\/\/www.zlk.com\/pslra-1\/abbott-laboratories-class-action-lawsuit-submission-form?prid=32018&amp;wire=4 ABT\u00a0investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ABT LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-687861","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ABT LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ABT LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK\u00a0, Sept. 22, 2022 \/PRNewswire\/ &#8212; Levi &amp; Korsinsky, LLP notifies investors in Abbott Laboratories (&#8220;Abbott&#8221; or the &#8220;Company&#8221;) (NYSE: ABT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Abbott investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities who purchased or otherwise acquired shares of Abbott common stock during the period from February 19, 2021, to June 8, 2022, inclusive. Follow the link below to get more information and be contacted by a member of our team: https:\/\/www.zlk.com\/pslra-1\/abbott-laboratories-class-action-lawsuit-submission-form?prid=32018&amp;wire=4 ABT\u00a0investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According &hellip; Continue reading &quot;ABT LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-22T09:49:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ABT LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline\",\"datePublished\":\"2022-09-22T09:49:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\"},\"wordCount\":481,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1687309\\\/LK_1920x1080_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\",\"name\":\"ABT LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1687309\\\/LK_1920x1080_Logo.jpg\",\"datePublished\":\"2022-09-22T09:49:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1687309\\\/LK_1920x1080_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1687309\\\/LK_1920x1080_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ABT LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ABT LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","og_locale":"en_US","og_type":"article","og_title":"ABT LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","og_description":"PR Newswire NEW YORK\u00a0, Sept. 22, 2022 \/PRNewswire\/ &#8212; Levi &amp; Korsinsky, LLP notifies investors in Abbott Laboratories (&#8220;Abbott&#8221; or the &#8220;Company&#8221;) (NYSE: ABT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Abbott investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities who purchased or otherwise acquired shares of Abbott common stock during the period from February 19, 2021, to June 8, 2022, inclusive. Follow the link below to get more information and be contacted by a member of our team: https:\/\/www.zlk.com\/pslra-1\/abbott-laboratories-class-action-lawsuit-submission-form?prid=32018&amp;wire=4 ABT\u00a0investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According &hellip; Continue reading \"ABT LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-22T09:49:21+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ABT LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline","datePublished":"2022-09-22T09:49:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/"},"wordCount":481,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","name":"ABT LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.jpg","datePublished":"2022-09-22T09:49:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abt-lawsuit-alert-levi-korsinsky-notifies-abbott-laboratories-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ABT LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/687861","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=687861"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/687861\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=687861"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=687861"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=687861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}